No products in the cart.
Ruxolitinib
Brand: ALIRUXOLITINIB
Manufacturer: Lao Alliance Pharmaceutical.
Prescription medicine. Use only under the guidance of a qualified healthcare professional.
Quick answer
Ruxolitinib is a prescription medicine (brand: ALIRUXOLITINIB), manufactured by Lao Alliance Pharmaceutical, supplied as 20mg/tab 56 tabs/bottle. It is dispensed by Daqi Hospital only against a valid prescription and must be used under medical supervision.
Key facts
| Name | Ruxolitinib |
|---|---|
| Brand | ALIRUXOLITINIB |
| Manufacturer | Lao Alliance Pharmaceutical |
| Product type | Prescription medicine |
| Strength / pack | 20mg/tab 56 tabs/bottle |
| Category | Immunomodulators |
| SKU | LAO-ALIRUXOLITINIB |
| Price | $945.00 |
| Availability | Available |
| Prescription required | Yes |
Frequently asked questions
What is Ruxolitinib?
Ruxolitinib is a prescription medicine (brand: ALIRUXOLITINIB), manufactured by Lao Alliance Pharmaceutical, supplied as 20mg/tab 56 tabs/bottle. It is dispensed by Daqi Hospital only against a valid prescription.
Who manufactures Ruxolitinib?
Ruxolitinib is manufactured by Lao Alliance Pharmaceutical.
What strength or pack size does Ruxolitinib come in?
Ruxolitinib is supplied as 20mg/tab 56 tabs/bottle.
Do I need a prescription to buy Ruxolitinib?
Yes. Ruxolitinib is a prescription medicine and is dispensed only against a valid prescription from a qualified healthcare professional.
How should Ruxolitinib be stored?
Store as directed by the manufacturer, in a cool, dry place away from direct sunlight and out of reach of children.
Where can I get more information about this product?
Contact Daqi Hospital or consult a qualified healthcare professional for guidance specific to your situation.
Important information
This information is provided for general reference only, is not medical advice, and does not replace consultation with a qualified healthcare professional. Prescription medicines are dispensed only against a valid prescription.








Reviews
There are no reviews yet.